News
-
-
PRESS RELEASE
Norgine announces Swissmedic approval of PEDMARQSI® for the prevention of cisplatin induced hearing loss in children
Norgine announces Swissmedic approval of PEDMARQSI(R) for the prevention of cisplatin induced hearing loss in children. PEDMARQSI(R) becomes the first treatment in Switzerland for this medical need -
-